Concord Biotech IPO: Established in the year 1984, Concord Biotech Limited has successfully established itself as one of the leading developers and manufacturers in its segment, Globally. The company produces and supplies fermented active pharmaceutical ingredients (APIs), immunosuppressants, oncology, nephrology, and anti-infective drugs all over the world.
In 2022, the company has been ranked as one of the top companies in its field. Recently they have started supplying their products in more than 70 countries including Europe, the USA, India, and Japan.
When the company was established it started with a single product. Now they have a vast range of products that are popular worldwide and now successfully made them one of the Biotech Giant Companies.
CONCORD BIOTECH IPO OVERVIEW
Now Concord Biotech Limited is all set to open its IPO on 4th August 2023. On August 18, 2023, they will list their IPOs on BSE and NSE.
Retail investors, who are interested in bidding for Concord Biotech Limited IPO, can go through this article to learn about Concord IPO reservation, IPO details, Lot(s) size, and Pros and Cons of investing in Concord IPO bio in detail.
Concord Biotech IPO is a book-built Issue type. That means the price at which all of the shares must be sold is decided by an underwriter. The face value of the Concord Biotech IPO is just 1 Rs. Per share. The lot (s) size is 20 shares. The total issue size of Concord Biotech IPO is 1551.00 crore INR. We have mentioned further details below.
|Company name||Concord Biotech Limited|
|IPO Date||From August 4, 2023 to August 8, 2023|
|Face value||1 INR per share.|
|Price band||705 to 741 INR per share|
|Lot(s) size||20 shares|
|Listing date||August 18, 2023|
|Issue size||20,925,652 shares|
|Discount for employees||70 INR per share|
|Type of Issue||Book built Issue|
|Share hold pre-issue||104,616,204|
|Listing at||BSE, NSE|
RESERVATION OF CONCORD Biotech
|Retail Shares Offered||35% of the net issue or more.|
|QIB shares offered||50% of the net issue or less.|
|NII Shares Offered||15% of the net issue or more.|
CONCORD BIOTECH IPO LOT(S) SIZE
Lot(s) size is the minimum number of shares an investor needs to bid to apply for an IPO. Investors need to buy an IPO in the multiplication of Lot(s) size. Concord Biotech IPO Lot (s) size is 20 shares. So a single Lot retail will cost a minimum of 14820 Rs.
|Application||Share numbers||Lot(s)||Cost of IPO|
|S- HNI Minimum||280||14||207,480|
|B- HNI Minimum||1360||68||1,007,760|
|S- HNI maximum||1340||67||992,940|
CONCORD BIOTECH IPO PROMOTER HOLDING
Ankur Vaid and Sudhir Vaid are the Promoters of Concord Biotech Limited company.
|Share holding of the pre-issue||44.08%|
|Shareholding of the post issue||44.08%|
CONCORD BIOTECH IPO IMPORTANT DATES
|IPO open date||4th August 2023|
|IPO close date||8th August 2023|
|Date of allotment||11th August 2023|
|Refunds initiation||14th August 2023|
|Share credit to Demat||17th August 2023|
|Time for UPI mandate confirmation||8th August 2023.|
|Listing Date||18th August 2023|
CONCORD BIOTECH IPO GMP
Grey Market Premium is the best way to understand the real story of the stock market. Even more than the actual price it’s the GMP trend that gives up the deep insights of the market. Here is the Concord Biotech IPO GMP data for the past few days.
|29 July 2023||330 INR.|
|30th July 2023||325 INR.|
|31st July 2023||205 INR.|
|1st August 2023||180 INR.|
|2nd August 2023||150 INR.|
|3rd August 2023||150 INR|
From the above chart, it is quite clear that even though the GMP started at around 330 INR later it decreased to 150 INR. But when the issue will open on 4th August 2023 it is expected to have a great impact on the subscription numbers. So we need to wait until the issue opens.
CONCORD BIOTECH LIMITED COMPANY FINANCE
|Content||31st March 2021 (Rs. in Million)||31st March 2022 (Rs.in million)||31st March 2023 (Rs.in Million)|
|Profit after Tax||2348.87||1749.29||2400.84|
|Earning per share||22.45||16.72||22.95|
CONCORD BIOTECH IPO ALLOTMENT STATUS
Investors can check the allotment status on the NSE website. If the application of investors somehow gets rejected their amount will be refunded. The Concord Biotech allotment is expected to be available on 11th August 2023. Once the Concord Biotech IPO gets closed, the refund process is supposed to be started soon. The credit will be transferred into the Demat account of the investors. The refund is expected to be started on 14th August 2023.
HOW TO APPLY FOR CONCORD BIOTECH IPO?
Interested investors can apply for Concord Biotech IPO online via UPI. They can also use ASBA as their payment method. The latter option will be available in the net banking system of the investor’s bank account. The other method of applying for Concord Biotech IPO is to apply through brokers. But they won’t offer banking services.
Pros and Cons of CONCORD BIOTECH IPO
1. There has been an impressive surge in the net worth of the company in the last two years. The net worth of the company has surged from 9993 Million in the year 2021 to 12900 million in the year 2023.
2. Concord Biotech Limited is one of the leading industries in its sector with over 20% market share in the year 2022.
1. Over 50% of the raw material of this company comes from China. If for any reason the supply gets interrupted that will have an adverse effect on the company’s growth.
2. If the company somehow can’t get the patent and trademark on any of its products the business will be affected.
FREQUENTLY ASKED QUESTIONS ABOUT CONCORD BIOTECH IPO
When will Concord Biotech IPO open?
Concord Biotech IPO will be available from August 4, 2023.
What is the Lot (s) size of Concord Biotech IPO?
The lot size of Concord Biotech IPO is 20 shares. That means a minimum investment of 14820 INR.
When is Concord Bio IPO allotment date?
The basis allotment of Concord Biotech IPO will take place on 11th August 2023. The refund process is expected to start on 14th August 2023.
Who is the owner of Concord Biotech?
Sudhir Vaid is the owner. He is also the Chairman and MD of Concord Pharma and Ankur Vaid is the CEO.